الصفحة الرئيسية>>Signaling Pathways>> DNA Damage/DNA Repair>> PARP>>Tankyrase-IN-2

Tankyrase-IN-2

رقم الكتالوجGC37735

Tankyrase-IN-2 (المركب 5k) هو مثبط فعال ، انتقائي ، وفعال عن طريق الفم (IC50s من 10 و 7 و 710 نانومتر لـ TNKS1 و TNKS2 وكذلك PARP1 ، على التوالي)يحتوي Tankyrase-IN-2 على خصائص فيزيائية كيميائية وخصائص حركية دوائية تعدل نشاط مسار Wnt في نموذج طعم أجنبي للقولون والمستقيم

Products are for research use only. Not for human use. We do not sell to patients.

Tankyrase-IN-2 التركيب الكيميائي

Cas No.: 1588870-36-3

الحجم السعر المخزون الكميّة
100mg Please Inquire Please Inquire
250mg Please Inquire Please Inquire
500mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally active tankyrase inhibitor (IC50s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulating Wnt pathway activity in a colorectal xenograft model[1]. IC50: 10 nM (TNKS1), 7 nM (TNKS2), 710 nM (PARP1)[1]

Tankyrase-IN-2 (1-10000 nM; 24 hours) leads to a dose-dependent increase of tankyrase protein abundance with an EC50 of 320 nM in DLD1 cells. This is in the same potency range as the value for axin2 increase (EC50=319 nM)[1].

[1]. Buchstaller HP, et al. Discovery and Optimization of 2-Arylquinazolin-4-ones into a Potent and Selective TankyraseInhibitor Modulating Wnt Pathway Activity. J Med Chem. 2019 Aug 5.

مراجعات

Review for Tankyrase-IN-2

Average Rating: 5 ★★★★★ (Based on Reviews and 10 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tankyrase-IN-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.